Profound Medical Corp
Company Profile
Business description
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Contact
2400 Skymark Avenue
Unit 6
MississaugaONL4W 5K5
CANT: +1 647 476-1350
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
142
Stocks News & Analysis
stocks
Picking dividend shares in 2026? Here’s where to look
stocks
Ahead of earnings, is Nvidia a buy, a sell, or fairly valued?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,915.70 | 38.20 | 0.43% |
| CAC 40 | 8,122.90 | 47.19 | -0.58% |
| DAX 40 | 23,672.83 | 203.72 | -0.85% |
| Dow JONES (US) | 47,147.48 | 309.74 | -0.65% |
| FTSE 100 | 9,686.92 | 11.45 | -0.12% |
| HKSE | 26,384.28 | 188.18 | -0.71% |
| NASDAQ | 22,900.59 | 30.23 | 0.13% |
| Nikkei 225 | 50,323.91 | 52.62 | -0.10% |
| NZX 50 Index | 13,499.04 | 34.58 | 0.26% |
| S&P 500 | 6,734.11 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,636.40 | 32.30 | 0.38% |
| SSE Composite Index | 3,972.03 | 18.46 | -0.46% |